ADRs End Lower; Genetic Technologies Declines 23%
This article was automatically generated by Dow Jones Newswires using technology from Automated Insights.
International stocks trading in New York closed lower on Thursday, as the S&P/BNY Mellon index of American depositary receipts declined 0.7% to 170.78.
The European index declined 0.4% to 166.52. The Asian index fell 1.3% to 197.94. The Latin American index dropped 0.2% to 203.38, while the emerging-markets index fell 1.6% to 314.32.
Genetic Technologies, based in Australia, posted the largest fall to close down 23% at $2.44, followed by shares of China's Canaan, which plunged 17% to 92 cents. Shares of Hong Kong-based iClick Interactive Asia Group lost 14% to $3.37.
Japan's Warrantee was the biggest leader during the session, and soared 43% to 46 cents, and Italy-based Genenta Science rallied 31% to $3.92. VIA optronics, which is based in Germany, rounded out the top three leaders on Thursday, with shares that gained 22% to 32 cents.
Data source: Dow Jones Market Data, FactSet.
(END) Dow Jones Newswires
April 18, 2024 16:54 ET (20:54 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters